Clinical trials
Phase 2 Urogenital Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 5 |
| Terminated | 5 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| NanOlogy, LLC | 2 |
| University of California, Irvine | 2 |
| Alessandro D'Agnolo | 1 |
| Cedars-Sinai Medical Center | 1 |
| Celldex Therapeutics | 1 |
| Dana-Farber Cancer Institute | 1 |
| Dendreon | 1 |
| Eli Lilly and Company | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Neoplasms | 18 |
| Prostatic Neoplasms | 8 |
| Genital Neoplasms, Male | 6 |
| Breast Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Carcinoma, Renal Cell | 4 |
| Kidney Neoplasms | 4 |
| Neoplasms | 4 |
| Neoplasms by Site | 4 |
| Prostatic Diseases | 4 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.